PRL and Disorder of lipid metabolism: In this study, compared with the control group, the NCNLL and NCNLH groups can regulate the levels of PRL, T4, E2, Ca, UREA, GLU, ALT, AST, TCHO, and TG in the serum, indicating that NCNL at either low or high doses can improve bromocriptine-induced lactation disorder, glucose, and lipid metabolism disorder through regulating the level of lactation-associated hormones in the serum of female adult rats.